You don't have to be in the healthcare industry for long before it becomes obvious that change is the only constant. Late in 2004, Christopher Koller conducted an interview with MANAGED HEALTHCARE EXECUTIVE and talked about his job as CEO of Providence-based Neighborhood Health Plan of Rhode Island (NHPRI), which was created in 1993 by the state's 14 Community Health Centers.
Just before going to press, however, Koller-who had served as the company's CEO since 1996-was nominated by Gov. Donald Carcieri to be Rhode Island's first-ever Health Insurance Commissioner, a role that will make him the point person for all healthcare access and affordability initiatives in the state.
"As CEO of Neighborhood Health Plan of Rhode Island, Chris is a nationally recognized leader in the healthcare field," Carcieri says. "He has long been acknowledged as Rhode Island's most innovative advocate for high-quality, affordable healthcare. His long background in healthcare management, as well as his stewardship of Neighborhood Health Plan, make him the perfect candidate for the job."
What went before Having coordinated care for the Medicaid population for the last decade provided experience that will serve Koller well in his new role.
"The statutory mandate of the Health Insurance Commissioner is 'to look at the healthcare system as a whole.' Insurance payment and benefit policies have profound effects on the behavior of consumers and providers," he says. "At NHPRI, we used them to increase behavioral health provider capacity and pay for quality. We also focused on improving access to care: the insurance card, plus an educated consumer and a collaborative provider. My challenge as Health Insurance Commissioner will be to help our health system evolve thoughtfully and have insurance practices that foster evolution."
Among his many accomplishments at NHPRI was presiding over the health plan in a state that is a national leader in Medicaid managed care and has the lowest rate of uninsured children in the country.
In 1996, NHPRI was a 27,000 member health plan with $30 million in revenue, about 40 people on staff, and a net worth of about $200,000. "I signed all the provider checks myself every week, knew the daily inpatient census, and spent a good deal of my days convincing major hospitals and regulators that we could make the trains run on time," Koller says. Eight and half years later-with 180 employees, $175 million in annual revenues and a net worth of $13 million-the plan is hardly a gorilla, but "that is the point-we collaborate with providers and members in way that is often innovative," Koller says. "Local providers who shunned us as the 'poor folks plan' now hold us up as the model. The same is true for well-run Medicaid managed care plans around the country. Providers respect our focus on collaborating with them to improve access."
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
Conversations With Perry and Friends
April 14th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. His guest this episode is John Baackes, the former CEO of L.A. Care Health Plan.
Listen
Women PCPs Have Equal or Better Medicare Patient Outcomes Than Men PCPs in Value-Based Care Model
June 24th 2025Women primary care providers (PCPs) treating Medicare patients in a value-based care model achieved better patient outcomes and earned more per patient than male counterparts, despite receiving equal patient satisfaction ratings, highlighting a potential for value-based payment to help close the gender pay gap.
Read More
A Progress Report on Chronic GVHD. The Grades Are Not So Great
June 24th 2025There has been no or some progress in most areas since a National Institute of Health consensus development project in 2020, according to a group of experts. But exception is important: Prevention of moderate or severe chronic graft-vs.-host disease.
Read More